IP Library Patent Application 13464285
Patent Application
App. No. 13/464,285

DNA SEQUENCING METHOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/464,285
Filed
May 4, 2012
Art Unit
1637
USPC
435/6.1
Abstract

A method for determining the sequence of a polynucleotide, the method relying on the detection of a conformational change in an enzyme that interacts with and processes along the polynucleotide. The detection of a conformational change may be carried out by measuring changes in a fluorophore bound to the enzyme.

Claims (19)

1 - 6 . (canceled)

7 . A method for determining the sequence of a polynucleotide, comprising the steps of:

(i) contacting a labeled polynucleotide processive enzyme with an unlabeled target polynucleotide to form a complex, wherein the detectable characteristics of the label alter as the enzyme processes along the target polynucleotide;

(ii) detecting an effect as the enzyme processes along the polynucleotide, thereby determining the sequence of the target polynucleotide, wherein the effect is detected by measuring the change of the detectible characteristics of the label.

8 . The method of claim 7 , wherein the effect is a conformational change in the enzyme.

9 . The method according to claim 7 , wherein a second detectable label is bound to a nucleotide brought into contact with the enzyme.

10 . The method according to claim 9 , wherein the second detectable label interacts with the label on the enzyme, wherein the degree of interaction of the labels is dependent on the proximity of the label on the enzyme and the second detectable label.

11 . The method according to claim 10 , wherein the label on the enzyme is an energy acceptor and the second detectable label is an energy donor, or wherein the label on the enzyme is an energy donor and the second detectable label is an energy acceptor, and wherein the detection step is carried out by measuring energy transfer between the two types of labels.

12 . The method according to claim 7 , wherein the enzyme is a polymerase enzyme and the method further comprises contacting the complex with one or more nucleoside triphosphates selected from the group consisting of dATP, dTTP, dGTP, and dCTP, under conditions sufficient to induce polynucleotide processive enzyme activity.

13 . The method according to claim 12 , wherein the effect is a conformational change in the polymerase that is brought about when the polymerase incorporates a nucleoside triphosphate into a nascent nucleotide strand complementary to the target polynucleotide.

14 . The method according to claim 12 , wherein the nucleoside triphosphates are labeled.

15 . The method according to claim 7 , wherein the enzyme is a helicase enzyme or a primase enzyme.

16 . The method according to claim 7 , wherein the enzyme and/or the complex is immobilized on a solid support.

17 . The method according to claim 16 , comprising a plurality of enzymes and/or complexes immobilized on the solid support.

18 . The method according to claim 7 , wherein the labeled polynucleotide processive enzyme comprises a single label or a single type of label.

19 . The method according to claim 7 , wherein the detection is carried out by measuring a polarisation effect consequent on the altered characteristics of the label.

20 . The method according to claim 19 , wherein the detection is carried out by fluorescence polarisation anisotrophy.

21 . The method according to claim 7 , wherein the detecting step is repeated one or more times utilizing the same complex.

22 . The method according to claim 21 , wherein the contacting and/or detecting step occur under conditions sufficient to induce enzyme activity.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →